Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 31715152.
- Also identified by DOI 10.1016/j.athoracsur.2019.09.056.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anticoagulation with unfractionated heparin is vital to reduce the risk of thromboembolic events during cardiopulmonary bypass and left ventricular assist device placement. However patients with heparin-induced thrombocytopenia are at risk of developing immune-mediated thrombotic events. We describe 2 patients with heparin-induced thrombocytopenia confirmed via serotonin release assay who were successfully treated with plasmapheresis exchange before left ventricular assist device placement.
Medical subject headings
- Heart-Assist Devices
- Heparin
- Plasmapheresis
- Thrombocytopenia
- Thrombosis